Understanding cardiopulmonary risk in COPD | This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only.
21 Oct 2025
Cardiovascular Professional Care Theatre
Cardiovascular Professional Care
This session aims to establish the importance of assessing cardiopulmonary risk and embedding the Cardiopulmonary Risk Matrix – a practical framework for systemically assessing and managing this risk in patients with COPD into clinical practice.
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
.png/fit-in/1280x9999/filters:no_upscale())
){kind=logo}
){kind=logo}
